Health Condition 1: - Health Condition 2: I978- Other intraoperative and postprocedural complications and disorders of the circulatory system, not elsewhere classified
Conditions
Interventions
Intervention1: esmolol 0.75 mg/kg: Group E patients will receive IV bolus of esmolol 0.75 mg/kg diluted in 20 ml with normal
saline given 2 min before intubation.
Control Intervention1: dexmedetomidin
Sponsors
Vigneshwaran C
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and ASA 2
Exclusion criteria
Exclusion criteria: patients with ischemic heart disease, hypertension, Diabetes mellitus, pregnant, anticipated difficult airway, duration of laryngoscopy more than 20 seconds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the clinical effects of dexmedetomidine and esmolol SBP,DBP,MAP,Heart rate,SpO2 recording Timepoint: SBP,DBP,MAP,Heart rate,SpO2 recording At baseline At 60 sec after infusion of dexmedetomidine/ esmolol Immediately after induction At 1 min after intubation At 3 min after intubation At 5 min after intubation At 10 min after intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| Attenuation of hemodynamic responses during laryngoscopy and endotracheal intubation.Timepoint: SBP,DBP,MAP,Heart rate,SpO2 recording At baseline at 60 sec after infusion of dexmedetomidine/ esmolol Immediately after induction At 1 min after intubation At 3 min after intubation At 5 min after intubation At 10 min after intubation | — |
Countries
India
Contacts
Public ContactVishwanath R Hiremath
Sri Manakula Vinayagar Medical College and Hospita
Outcome results
None listed